
NASDAQHealthcareMedical - Devices
最新データ
$13.00
−$0.32 · -2.40%
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
前日終値
$13.00
−$0.32 · -2.40%
時間外
$13.00
$0.00 · 0.00%
10月7日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
63
割安
センチメント
64
強気
リスク
41
やや高いリスク
モメンタム
70
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 16.35億 USD | 16.11億 USD | 15.42億 USD | 15.58億 USD | 15.42億 USD |
| 売上原価 | 7.9億 USD | 7.28億 USD | 6.57億 USD | 5.87億 USD | 5.98億 USD |
| 粗利益 | 8.45億 USD | 8.82億 USD | 8.85億 USD | 9.7億 USD | 9.45億 USD |
| 研究開発 | 9897.1万 USD | 1.15億 USD | 1.04億 USD | 1.01億 USD | 9305.1万 USD |
| 販売・一般管理 | 7億 USD | 7.17億 USD | 6.57億 USD | 6.16億 USD | 6.37億 USD |
| 営業費用 | 7.77億 USD | 8.54億 USD | 7.73億 USD | 7.31億 USD | 7.47億 USD |
| 受取利息 | 1847.4万 USD | 2004万 USD | 1720.2万 USD | 1191.7万 USD | 673.7万 USD |
| 支払利息 | 8625.5万 USD | 7063.2万 USD | 5137.7万 USD | 4959.4万 USD | 5039.5万 USD |
| 減価償却費と償却費 | 1.52億 USD | 1.41億 USD | 1.24億 USD | 1.18億 USD | 1.2億 USD |
| 営業利益 | 6831.8万 USD | 2841.1万 USD | 1.12億 USD | 2.39億 USD | 1.97億 USD |
| 純利益 | −5.16億 USD | −694.4万 USD | 6774.1万 USD | 1.81億 USD | 1.69億 USD |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$19.40
上昇余地(49.23%)| 種別 | 発効日 | 詳細 | 基準日 | 支払日 |
|---|---|---|---|---|
株式分割 | 2017年1月4日 | 2:1 | — | — |
株式分割 | 2015年7月1日 | 553:500 | — | — |
株式分割 | 1998年5月26日 | 1:2 | — | — |
発効済み 2017年1月4日
2:1
発効済み 2015年7月1日
553:500
発効済み 1998年5月26日
1:2
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI3567.24万0.00%2.3兆 USD0.03%$381.03-0.40%
Vanguard Morningstar Small-Cap ETFVB2571.18万0.01%1853億 USD0.03%$286.98-1.41%
iShares Russell 2000 ETFIWM2373.16万0.03%785.63億 USD0.19%$277.7-1.29%
Vanguard Morningstar Small-Cap Value ETFVBR1634.93万0.02%682億 USD0.05%$232.17-1.32%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1427.99万0.05%266.88億 USD0.33%$37.79-1.23%
Vanguard Extended Market ETFVXF1317.01万0.01%954億 USD0.05%$233.49-1.56%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM809.72万0.05%160.11億 USD0.03%$53.28-1.32%
Vanguard Russell 2000 ETFVTWO665.5万0.04%180億 USD0.06%$112.21-1.26%
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Vanguard Russell 2000 ETFVTWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。